↑Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L (March 1994). “[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study]”. Urologe A (in German). 33 (2): 138–43. PMID8178408.CS1 maint: Multiple names: authors list (link) CS1 maint: Unrecognized language (link)
